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Ancona University Politecnica Delle Marche, Ancona, Italy  
Obesity is increasing worldwide together with its companions hypertension 
and type 2 diabetes. The obese hypertensive patients are usually at high 
cardiovascular risk because derangements of glucose and lipids metabolism 
are also present. A study in 3 different populations suggested a relationship 
between the TCF4 gene microsatellite DG10S478 allele “X” (with more than 
5 TTTC repetitions) and type 2 diabetes. This genetic marker may be 
especially useful to identify patients with susceptibility to diabetes in a 
population with high cardiovascular risk and increased incidence and 
prevalence of diabetes. Thus, the objectives of this study were: 1) identify the 
carriers of TCF4 allele X among obese hypertensives; 2) verify the 
prevalence of the X allele in comparison to healthy subjects. We studied 131 
obese hypertensives without diabetes, and 146 healthy subjects as control 
population. Genotyping of the microsatellite was performed by PCR and 
direct sequencing. The allelic frequencies were similar (allele X = 37.4%) to 
those found in the previous published study on 3 different population. We 
didn’t find a higher allele X frequency in obese hypertensives compared to 
the control group (39.7% vs. 35.3%, P=0.323). Furthermore, there were no 
allele X-related differences in BMI and waist among groups (P=0.76). We 
conclude that, although TCF4 X allele could be useful to identify obese 
hypertensives that might develop diabetes, its prevalence is not increased in 
this population. Thus, accordingly to the previous published work, allele X 
associates with type 2 diabetes through mechanisms not linked to obesity and 
related consequences. 
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Aims: Central obesity is associated with increased cardiovascular morbidity and
mortality. It has been proposed that increased lipid accumulation in vascular tissue
and the consequent increase in oxidative stress may be a missing link between
obesity and atherosclerosis. The peroxisome proliferators -activated receptor
(PPAR) –gamma coactivator 1 -alpha (PGC-1alpha) is a transcriptional coactivator
playing an important role in energy met abolism. PGC -1alpha is present in
vascular cells, but its role in vascular endothelial cells has not been established. In
this study, we examined the effect of adenoviral overexpression of PGC-1alpha
(Ad-PGC-1alpha) in human aortic endothelial cells (HAECs ) on apoptosis induced
by linoleic acid (LA). 
Methods: Effect of PGC-1 on HAECs apoptosis was evaluated by ELISA, WST -1
assay, and caspase activity. Using Ad -PGC-1 and ANT-1 siRNA, effect of PGC-1
and ANT-1 on reactive oxygen species (ROS) production, fa tty acid oxidation
(FAO) and mitochondrial membrane potential (mtMP) were analyzed. 
Results: PGC-1alpha prevented LA-induced endothelial apoptosis. PGC -1alpha
also reduced LA-induced increases of antioxidant enzyme expression and ROS
accumulation at basal state. LA decreased the activity of adenosine nucleotide
translocase (ANT), and increased mtMP. In the Ad-PGC-1alpha-infected HAECs,
activity and the mRNA expression of ANT -1 were increased and LA did not
increase mtMP. siRNA against ANT-1 reversed the cha nges induced by PGC -
1alpha.  
Conclusion: These data suggest that PGC -1alpha functions as a physiologic
regulator of ROS generation in endothelial cells and that part of this effect is medi
ated by ANTdependent increase in FAO. 
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University of California, Riverside, USA 
Our previous research showed that female mice selectively bred for high 
voluntary wheel running activity are resistant against high fat diet-
induced obesity, despite increased high fat intake in these mice relative 
to female controls . Since high fat feeding relates to brain serotonin 
levels and mood regulation, w e investigated whether selected mice 1) 
have altered diet selection when given a choice of fat and carbohydrates, 
2) have different perfomances in behavioral tests (i.e., plus maze, open 
field, complex maze), and 3) have differences in biogenic amine levels in 
discrete brain regions relative to controls. When given choice, selected 
mice strongly preferred high carbohydrate diet over the fat diet, 
irrespective of the regular diet (i.e., chow or high fat food). Secondly, 
selected animals had a higher level of anxiety, as ev idenced by higher 
closed –arm occupation in the plus maze relative to cont rols, but 
selected animals were more explorative in open field and complex maze. 
Finally, levels of serotonin, but not of the 5HT metabolite 5HIA, were 
markedly suppressed in prefrontale cort ices of selected females and 
males, an effect that was more pronounced in animals feeding the high 
fat diet than those feeding chow. The results indicate that low brain ser 
otinin levels in high activity mice may underlie reduced fat selection and 
their increased state of anxiety. They do not explain, however, the higher 
level of spontaneous activity and explorative bevaviour in these selected 
mice. 
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Rosiglitazone reduce macrophage and chemokine expression but increase  















Dept. Of Endocrinology And Metabolism C 
Visceral obesity is a chronic low-grade inflammatory state associated with
insulin resistance, type 2 diabetes, and cardiovascular disease. Human
adipose tissue (AT) seems to be involved in the abovementioned deleterious
health effects of obesity through the production of inflammatory proteins.
Rosiglitazone is a PPAR -agonist with known anti-diabetic effects and
reported anti-inflammatory effects.  Aim of the study was to investigate the
long-term effects of Rosiglitazone (4mg daily) on ATmRNA levels of
macrophage specific markers [CD14, CD68], chemokines, and chemokine
receptors in six abdominally obese male subjects (mean age: 50.2 ± 2.9 yrs,
mean BMI: 29.3 ± 1.0 kg/m
2
, mean waist: 98.7 ± 1.2 cm). AT-biopsies were
obtained from the subcutaneous abdominalAT-depot at baseline, after 3, and
6 months, at which time AT-mRNA l evels were quantified using a real time
RT-PCR method. Rosiglitazone reduced mRNA levels of CD14 (P<0.05),
CD68 (P<0.01), MCP-1 (P<0.01), MIP-1 (P<0.05), and IL-8 non-significant
(P=0.06) but increased mRNA levels of the equivalent chemokine receptors:
CCR2 (P<0.05), CXC2 (P<0.05), and CXC1 non-significant (P=0.07). In
conclusion, Rosiglitazone was for the first time found to exert anti-
inflammatory effects in human AT in vivo, reducing mRNA levels of
macrophage specific markers [CD14, CD68] and various chemokines. In
parallel, increasing mRNA levels of the equivalent chemokine receptors were
found. This suggests, that a complex interaction may exist between AT-
inflammation and the need for chemokines to attract cell-types involved in
tissue homeostasis [e.g. macrophages, leucocytes]. 
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